Study The Clinical Effect Of Gairikadi Gutikanjan In Vataj Abhishyanda

Randomized Open Controlled Clinical Study To Evaluate The Efficacy Of Gairikadi Gutikanjan In Vataj Abhishyanda w.s.r. To Simple Allergic Conjunctivitis - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101364

Enrollment

Registered

2026-01-16

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis Health Condition 2: H108- Other conjunctivitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patient having signs and symptoms of Vataj Abhishyanda described by ayurveda and patient having signs and symptoms of allergic conjunctivitis described in modern scince will be included 2) Patients with unilateral or bilateral vataj abhishyanda 3) Irrespective of gender socioeconomic status religion 4) The patients of age from 18 years to 50 years

Exclusion criteria

Exclusion criteria: 1) Patient having signs and symptoms other than Allergic Conjunctivitis 2) Patient having corneal involvement 3) Patients suffering from malignant conditions of eye 4) Patient having congenital anomalies of eyes 5) Patients having P/H/O any eye surgery 6) Patients who are contraindicated for anjan karma

Design outcomes

Primary

Measure	Time frame
To study the effect of Gairikadi Gutika anajan in Vataj AbhishyandaTimepoint: 15 days	—

Secondary

Measure	Time frame
1 To Assess the reduction in associated symptoms such as pain nistoda in patients of Vataj Abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 2 To assess the reduction in assosiate symptoms such as foreign body sensation in patients of Vataj abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 3 To assess the reduction in assosiate symptoms such as watering of eyes in patients of Vataj abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 4 To assess the reduction in assosiate symptoms such as congestion in eyes in patients of Vataj abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 5 To evaluate the tolerability and safety profile of Gairikadi Gutika when administered as Anjana over a treatment duration of 8 consecutive days 6 To assess pateint reported improvement in quality of life reduction in pain or watery discharge using a standard questionnaire before and after the interventionTimepoint: 15 days	—

Measure

Time frame

1 To Assess the reduction in associated symptoms such as pain nistoda in patients of Vataj Abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 2 To assess the reduction in assosiate symptoms such as foreign body sensation in patients of Vataj abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 3 To assess the reduction in assosiate symptoms such as watering of eyes in patients of Vataj abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 4 To assess the reduction in assosiate symptoms such as congestion in eyes in patients of Vataj abhishyanda after 8 days of Gairikadi Gutika Anjana therapy 5 To evaluate the tolerability and safety profile of Gairikadi Gutika when administered as Anjana over a treatment duration of 8 consecutive days 6 To assess pateint reported improvement in quality of life reduction in pain or watery discharge using a standard questionnaire before and after the interventionTimepoint: 15 days

—

Countries

India

Contacts

Public ContactDr Chandrashekhar Mule

Yashwant Ayurvedic Medical College PGT and RC Kodoli Kolhapur

drcnm05@gmail.com9175800710

Outcome results